List of Esmolol Hydrochloride Double Strength In Plastic Container drug patents

Esmolol Hydrochloride Double Strength In Plastic Container is owned by Hq Spclt Pharma.

Esmolol Hydrochloride Double Strength In Plastic Container contains Esmolol Hydrochloride.

Esmolol Hydrochloride Double Strength In Plastic Container has a total of 2 drug patents out of which 0 drug patents have expired.

Esmolol Hydrochloride Double Strength In Plastic Container was authorised for market use on 07 April, 2016.

Esmolol Hydrochloride Double Strength In Plastic Container is available in solution;intravenous dosage forms.

The generics of Esmolol Hydrochloride Double Strength In Plastic Container are possible to be released after 15 March, 2033.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8835505 HQ SPCLT PHARMA Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Mar, 2033

(9 years from now)

US8829054 HQ SPCLT PHARMA Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
Mar, 2033

(9 years from now)

Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient

Market Authorisation Date: 07 April, 2016

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic